Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Fingerprint
Dive into the research topics where Marina Kremyanskaya is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis
Handa, S., Ginzburg, Y., Hoffman, R. & Kremyanskaya, M., 1 Mar 2023, In: Current Opinion in Hematology. 30, 2, p. 45-52 8 p.Research output: Contribution to journal › Review article › peer-review
-
Anagrelide for platelet-directed cytoreduction in polycythemia vera: Insights into utility and safety outcomes from a large multi-center database
Rippel, N., Tremblay, D., Zubizarreta, N., Podoltsev, N., Gotlib, J., Heaney, M., Kuykendall, A., O'Connell, C., Shammo, J. M., Fleischman, A., Kremyanskaya, M., Hoffman, R., Mesa, R., Yacoub, A. & Mascarenhas, J., Aug 2022, In: Leukemia Research. 119, 106903.Research output: Contribution to journal › Article › peer-review
-
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
Mascarenhas, J., Kosiorek, H. E., Prchal, J. T., Rambaldi, A., Berenzon, D., Yacoub, A., Harrison, C. N., McMullin, M. F., Vannucchi, A. M., Ewing, J., O'Connell, C. L., Kiladjian, J. J., Mead, A. J., Winton, E. F., Leibowitz, D. S., De Stefano, V., Arcasoy, M. O., Kessler, C. M., Catchatourian, R., Rondelli, D., & 23 others, 12 May 2022, In: Blood. 139, 19, p. 2931-2941 11 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase
Wang, X., Rampal, R. K., Hu, C. S., Tripodi, J., Farnoud, N., Petersen, B., Rossi, M. R., Patel, M., McGovern, E., Najfeld, V., Iancu-Rubin, C., Lu, M., Davis, A., Kremyanskaya, M., Weinberg, R. S., Mascarenhas, J. & Hoffman, R., 22 Apr 2022, In: JCI insight. 7, 8, e156534.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
Wo, S., Levavi, H., Mascarenhas, J., Kremyanskaya, M., Navada, S., Bar-Natan, M. & Kim, S. S., 2022, In: Blood Research. 57, 2, p. 135-143 9 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Press/Media
-
Pelabresib Monotherapy Shows Benefit in JAK Inhibitor–Naïve Advanced Myelofibrosis
17/02/22
1 item of Media coverage
Press/Media
-
Ruxolitinib Remains Backbone in Myelofibrosis and MPN Treatment
4/01/22
1 item of Media coverage
Press/Media
-
Dr. Kremyanskaya on the Next Steps of the MANIFEST Trial in Myelofibrosis
3/01/22
1 item of Media coverage
Press/Media
-
Ruxolitinib Combos Are Making Strides in Myelofibrosis and MPNs
3/01/22
1 item of Media coverage
Press/Media
-
Dr. Kremyanskaya on the Design of the MANIFEST Trial in Myelofibrosis
21/12/21
1 item of Media coverage
Press/Media